Literature DB >> 22924643

Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats.

Lachlan R Gray1, Daniel Cowley, Emma Crespan, Casey Welsh, Charlene Mackenzie, Steve L Wesselingh, Paul R Gorry, Melissa J Churchill.   

Abstract

New evidence indicates that astrocytes of the central nervous system (CNS) are extensively infected with human immunodeficiency virus type 1 (HIV-1) in vivo. Although no new virus is produced, this nonproductive or restricted infection contributes to the pathogenesis of HIV-associated dementia (HAD) and compromises virus eradication strategies. The HIV-1 long terminal repeat (LTR) plays a critical role in regulating virus production from infected cells. Here, we determined whether LTRs derived from CNS and non-CNS compartments are genetically and functionally distinct and contribute to the restricted nature of astrocyte infection. CNS- and/or non-CNS-derived LTRs (n=82) were cloned from primary HIV-1 viruses isolated from autopsy tissues of seven patients who died with HAD. Phylogenetic analysis showed interpatient and intrapatient clustering of LTR nucleotide sequences. Functional analysis showed reduced basal transcriptional activity of CNS-derived LTRs in both astrocytes and T cells compared to that of non-CNS-derived LTRs. However, LTRs were heterogeneous in their responsiveness to activation by Tat. Therefore, using a relatively large, independent panel of primary HIV-1 LTRs derived from clinically well-characterized subjects, we show that LTRs segregate CNS- from non-CNS-derived tissues both genetically and functionally. The reduced basal transcriptional activity of LTRs derived from the CNS may contribute to the restricted HIV-1 infection of astrocytes and latent infection within the CNS. These findings have significance for understanding the molecular basis of HIV-1 persistence within cellular reservoirs of the CNS that need to be considered for strategies aimed at eradicating HIV-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924643      PMCID: PMC3552182          DOI: 10.1089/AID.2012.0138

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  27 in total

Review 1.  The Sp-family of transcription factors.

Authors:  G Suske
Journal:  Gene       Date:  1999-10-01       Impact factor: 3.688

Review 2.  Reverse transcription of retroviruses and LTR retrotransposons.

Authors:  M Wilhelm; F X Wilhelm
Journal:  Cell Mol Life Sci       Date:  2001-08       Impact factor: 9.261

Review 3.  Molecular mechanisms of nucleic acid integration.

Authors:  J M Coffin
Journal:  J Med Virol       Date:  1990-05       Impact factor: 2.327

4.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

5.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

6.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

7.  Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Authors:  P R Gorry; G Bristol; J A Zack; K Ritola; R Swanstrom; C J Birch; J E Bell; N Bannert; K Crawford; H Wang; D Schols; E De Clercq; K Kunstman; S M Wolinsky; D Gabuzda
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

Authors:  Paul R Gorry; Joann Taylor; Geoffrey H Holm; Andrew Mehle; Tom Morgan; Mark Cayabyab; Michael Farzan; Hui Wang; Jeanne E Bell; Kevin Kunstman; John P Moore; Steven M Wolinsky; Dana Gabuzda
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 9.  Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia.

Authors:  Paul R Gorry; Chi Ong; Janine Thorpe; Sylvie Bannwarth; Katherine A Thompson; Anne Gatignol; Steven L Vesselingh; Damian F J Purcell
Journal:  Curr HIV Res       Date:  2003-10       Impact factor: 1.581

10.  Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues.

Authors:  Lachlan Gray; Jasminka Sterjovski; Paul A Ramsland; Melissa J Churchill; Paul R Gorry
Journal:  Retrovirology       Date:  2011-06-02       Impact factor: 4.602

View more
  15 in total

1.  Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.

Authors:  Michael J Peluso; Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 2.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

Review 3.  HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Authors:  Melissa J Churchill; Daniel J Cowley; Steve L Wesselingh; Paul R Gorry; Lachlan R Gray
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

4.  Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.

Authors:  Lachlan R Gray; Hung On; Emma Roberts; Hao K Lu; Michael A Moso; Jacqueline A Raison; Catherine Papaioannou; Wan-Jung Cheng; Anne M Ellett; Jonathan C Jacobson; Damian F J Purcell; Steve L Wesselingh; Paul R Gorry; Sharon R Lewin; Melissa J Churchill
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

Review 5.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

Review 6.  Strategies to target non-T-cell HIV reservoirs.

Authors:  Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

7.  Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1.

Authors:  Christina C Chang; Vivek Naranbhai; Jared Stern; Michael Roche; Ashanti Dantanarayana; Ruian Ke; Surekha Tennakoon; Ajantha Solomon; Rebecca Hoh; Wendy Hartogensis; Frederick M Hecht; Ken Sikaris; David J Price; Julian H Elliott; Steven G Deeks; Melissa Churchill; Paul U Cameron; Nicolas Hengartner; Alan S Perelson; Sharon R Lewin
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.177

Review 8.  Is the central nervous system a reservoir of HIV-1?

Authors:  Lachlan R Gray; Michael Roche; Jacqueline K Flynn; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 9.  HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence

Authors:  Raj Putatunda; Wen-Zhe Ho; Wenhui Hu
Journal:  AIDS Rev       Date:  2019       Impact factor: 2.500

Review 10.  HIV and neurocognitive dysfunction.

Authors:  Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.